MATTHEW JAMES to Treatment Outcome
This is a "connection" page, showing publications MATTHEW JAMES has written about Treatment Outcome.
Connection Strength
0.344
-
Comparative Performance of Prediction Models for Contrast-Associated Acute Kidney Injury After Percutaneous Coronary Intervention. Circ Cardiovasc Qual Outcomes. 2019 11; 12(11):e005854.
Score: 0.052
-
Kidney Function Does Not Modify the Favorable Quality of Life Changes Associated With Revascularization for Coronary Artery Disease: Cohort Study. J Am Heart Assoc. 2016 07 19; 5(7).
Score: 0.041
-
Early-invasive strategies for the management of coronary heart disease in chronic kidney disease: is acute kidney injury a consideration? Curr Opin Nephrol Hypertens. 2014 May; 23(3):283-90.
Score: 0.036
-
Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol. 2013 Feb; 24(3):465-73.
Score: 0.033
-
Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography: a systematic review and meta-analysis. Circ Cardiovasc Interv. 2013 Feb; 6(1):37-43.
Score: 0.032
-
Hospital and Physician Variability in Revascularization Decisions and Outcomes for Patients With 3-Vessel and Left Main Coronary Artery Disease: A Population-Based Cohort Study. J Am Heart Assoc. 2024 Sep 17; 13(18):e035356.
Score: 0.018
-
Response shift in coronary artery disease. Qual Life Res. 2024 Mar; 33(3):767-776.
Score: 0.017
-
Simple Laboratory Test-Based Risk Scores in Coronary Catheterization: Development, Validation, and Comparison to Conventional Risk Factors. J Appl Lab Med. 2020 07 01; 5(4):616-630.
Score: 0.014
-
Costs and consequences of acute kidney injury after cardiac surgery: A cohort study. J Thorac Cardiovasc Surg. 2021 09; 162(3):880-887.
Score: 0.013
-
Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. JAMA Intern Med. 2020 03 01; 180(3):420-428.
Score: 0.013
-
Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury. JAMA Intern Med. 2018 12 01; 178(12):1681-1690.
Score: 0.012
-
Oral curcumin in elective abdominal aortic aneurysm repair: a multicentre randomized controlled trial. CMAJ. 2018 10 29; 190(43):E1273-E1280.
Score: 0.012
-
Trajectories of Health-Related Quality of Life in Coronary Artery Disease. Circ Cardiovasc Qual Outcomes. 2018 03; 11(3):e003661.
Score: 0.012
-
Multi-Disciplinary Vascular Access Care and Access Outcomes in People Starting Hemodialysis Therapy. Clin J Am Soc Nephrol. 2017 Dec 07; 12(12):1991-1999.
Score: 0.011
-
Examining the Association between Hemodialysis Access Type and Mortality: The Role of Access Complications. Clin J Am Soc Nephrol. 2017 Jun 07; 12(6):955-964.
Score: 0.011
-
Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis. BMC Nephrol. 2014 Apr 02; 15:53.
Score: 0.009
-
Ascorbic acid for anemia management in hemodialysis patients: a systematic review and meta-analysis. Am J Kidney Dis. 2009 Dec; 54(6):1089-97.
Score: 0.006